Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
10/09/1985 | EP0157384A2 Substrates for hydrolases, process for their preparation and their use |
10/09/1985 | EP0157362A2 Chromogenic amino acids and peptide esters, process for their preparation, use of these compounds in analytical processes, as well as agents for marking esterolytic and/or proteolytic enzymes |
10/09/1985 | EP0157275A1 Method for culturing transformed yeast |
10/09/1985 | EP0156961A2 Process for preparing highly purified, stroma-free and hepatitis-resisting human and animal haemoglobin solutions |
10/09/1985 | EP0156899A1 Synthetic peptides with egf like activity and pharmaceutical compositions and methods of use |
10/08/1985 | US4546161 Reacting triazine dyes with support |
10/08/1985 | US4546082 Dna expression vector |
10/08/1985 | US4546079 Iron containing or iron-free cultures |
10/08/1985 | US4545931 Synthetic heat-stable enterotoxin polypeptide of Escherichia coli |
10/08/1985 | CA1194794A1 Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom |
10/02/1985 | EP0156712A1 Useful composition for the manufacture of vaccines containing particles bearing a hepatitis B virus surface antigen and polymerized human seric albumin receptor, animal cells able toproduce such particles and process for their obtention |
10/02/1985 | EP0156537A2 Biological magnetic fluids |
10/02/1985 | EP0156373A2 Purified recombinant interleukin-2 and process for recovering and purifying same |
10/02/1985 | EP0156355A2 Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria |
10/02/1985 | EP0156354A2 Controlled oxidation of microbially produced cysteine containing proteins |
10/02/1985 | EP0156322A2 Renin inhibitors containing peptide isosteres |
10/02/1985 | EP0156321A2 Renin inhibitory peptides having improved solubility |
10/02/1985 | EP0156320A2 Renin inhibitors containing homophe 8 and a C-terminal amide cycle |
10/02/1985 | EP0156319A2 Renin inhibitors containing homophe 8 |
10/02/1985 | EP0156318A2 C-terminal amide cyclic renin inhibitors containing peptide isosteres |
10/02/1985 | EP0156299A2 LTR modified viral vaccines |
10/02/1985 | EP0156280A2 Process for the preparation of peptide intermediates poor in racemates, belonging to gonadorelin and gonadorelin analogues, their synthesis and intermediates obtained by this process |
10/02/1985 | EP0156266A2 Tissue protein PP21, process for obtaining it and its use |
10/02/1985 | EP0156242A2 Lyophilized hepatitis B vaccine |
10/02/1985 | EP0156063A2 Hypoglycaemic tetrapeptides |
10/01/1985 | US4544637 Bacteriology |
10/01/1985 | US4544632 Human T cell lines and method of producing same |
10/01/1985 | CA1194435A1 Amplified expression of dna sequences |
10/01/1985 | CA1194432A1 Human pregrowth hormone |
10/01/1985 | CA1194415A1 Immunoglobulin half-molecules and process for producing hybrid antibodies |
09/26/1985 | WO1985004188A1 Recombinant dna molecules |
09/26/1985 | WO1985004187A1 Process for preparing 5'-guanylic acid |
09/26/1985 | WO1985004186A2 A modified gamma interferon, dna sequences encoding it and processes for producing it |
09/26/1985 | WO1985004173A1 Bone protein purification process |
09/26/1985 | WO1985004169A1 Method and agents for measuring protein aging |
09/26/1985 | WO1985004103A1 Synthetic hepatitis b virus vaccine including both t cell anc b cell determinants |
09/25/1985 | EP0155852A2 Thrombin-binding substance and process for its production |
09/25/1985 | EP0155809A2 Renin inhibitors containing statine or derivatives thereof |
09/25/1985 | EP0155786A2 New peptide, and production and use thereof |
09/25/1985 | EP0155676A2 Process for obtaining the globular domains of basement membrane collagen, and immunological determination of basement membrane materials and auto-antibodies |
09/25/1985 | EP0155655A2 Process for production of insulin-like growth factor I |
09/25/1985 | EP0155590A2 Gene-technologic process for the preparation of human gamma-interferon, and means for carrying out this process |
09/25/1985 | EP0155577A1 Process for recovering subterranean stem starch and protein |
09/25/1985 | EP0155549A2 DNA encoding human tumor necrosis factor and human tumor necrosis factor polypeptide |
09/25/1985 | EP0155476A1 Production of polypeptides in insect cells |
09/25/1985 | EP0155433A1 Immunosuppressant factor |
09/25/1985 | EP0155319A1 Monoclonal anti-interleukin-2 antibody useful for immunopurification for interleukin-2 |
09/24/1985 | US4543340 Radioimmunoassay of thymosin β4 |
09/24/1985 | US4543329 Process for the specific cleavage of protein sequences from proteins |
09/24/1985 | US4543252 Cationic oligopeptides having microbicidal activity |
09/24/1985 | US4543211 Binding immunoglobulin to polymer |
09/24/1985 | US4543210 Process for producing a high purity antihemophilic factor concentrate |
09/24/1985 | US4543209 Process for preparing globin from haemoglobin and globin obtained by this process |
09/18/1985 | EP0155224A2 Solid-borne complex bearing chromagen responsive functionality for antibody, antigen, receptor, or ligand detection |
09/18/1985 | EP0155199A1 Hexapeptide, process for its preparation and pharmaceutical compositions thereof |
09/18/1985 | EP0155198A1 Yeast cloning and expression vectors for a protein in an eucaryotic cell, containing at least a part of a retrovirus genome; transfected eucaryotic cells; process using these cells and obtained proteins |
09/18/1985 | EP0155192A2 cDNA clones coding for polypeptides exhibiting IgE binding factor activity |
09/18/1985 | EP0155188A2 Alpha-1-antitrypsin mutants and DNA coding therefor and the production of each, and therapeutic formulations using such mutants and their preparation |
09/18/1985 | EP0155172A2 Anti-human lung cancer monoclonal antibodies |
09/18/1985 | EP0155147A2 The antigenic determinants of HBxAg |
09/18/1985 | EP0155146A2 Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
09/18/1985 | EP0155007A2 Method for purification of HBs antigen |
09/18/1985 | EP0154904A1 Acylamino oxo or hydroxy substituted alkylamino thiazines and thiazepines |
09/18/1985 | EP0154902A2 Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
09/18/1985 | EP0154886A2 Carboxyalkyl dipeptide derivatives, process for their preparation, agents containing them, and their use |
09/18/1985 | EP0154884A2 Nucleic acid-protein conjugate |
09/18/1985 | EP0154788A2 Detectable molecules, method of preparation and use |
09/18/1985 | EP0154625A1 Hybridoma cell line producing suppressive factor of allergy |
09/18/1985 | EP0050644B1 Sterilized, preserved, stable mucine-containing solutions and sterilization method |
09/17/1985 | US4542225 Acid-cleavable compound |
09/17/1985 | US4542124 Octapeptide vasopressin antagonists |
09/17/1985 | US4542017 Interleukins to stimulate metabolism |
09/17/1985 | US4542016 Non-a non-b hepatitis surface antigen useful for the preparation of vaccines and methods of use |
09/17/1985 | US4541952 Purification method of human interferon |
09/17/1985 | CA1193563A1 Expression vectoer of the antigenic proein of rabies and use for the preparation of vaccines |
09/12/1985 | WO1985003950A1 A sv40 expression vector containing hbxag as an expression marker |
09/12/1985 | WO1985003949A1 Hosts and methods for producing recombinant products in high yields |
09/12/1985 | WO1985003948A1 Macrophage activating factor |
09/12/1985 | WO1985003947A1 T-cell receptor-specific for antigen polypeptides and related polynucleotides |
09/12/1985 | WO1985003946A1 Hybrid cells producing a determined polypeptide |
09/12/1985 | WO1985003945A1 Recombinant plasmids; bacteria containing such recombinant plasmids; process for preparing fermented food products, animal feedstuffs, ingredients thereof or proteins using such bacteria |
09/12/1985 | WO1985003934A1 Chemically modified protein and process for its preparation |
09/12/1985 | WO1985003876A1 Composition useful for obtaining vaccines containing particles carrying the surface antigene of hepatitis b virus and the recepto r of polymerized human serum albumin, animal cells capable of p roducing such particles and method for the obtention thereof |
09/12/1985 | WO1985003868A1 Chemically modified lymphokine and process for its preparation |
09/11/1985 | EP0154587A2 Fragments of DNA which encode peptides capable of inducing in vivo the synthesis of anti-hepatitis A virus antibodies |
09/11/1985 | EP0154576A1 Hybrid nucleic acid sequences having tandemly arranged genes |
09/11/1985 | EP0154539A2 Recombinant DNA expression vectors and method for gene expression |
09/11/1985 | EP0154454A1 Cloning of DNA for protozoal antigens |
09/11/1985 | EP0154434A1 Human transforming growth factor and precursor or fragment thereof, cells, DNA, vectors and methods for their production, compositions and products containing them, and related antibodies and diagnostic methods |
09/11/1985 | EP0154316A2 Chemically modified lymphokine and production thereof |
09/11/1985 | EP0154284A2 DNA coding for a signal peptide and DNA containing the same |
09/11/1985 | EP0154186A2 Isolation of a novel interferon gene and expression thereof |
09/11/1985 | EP0154133A2 Plasmidic expression vehicles, and method of producing a polypeptide therewith |
09/11/1985 | EP0154066A1 Immunopotentiation agents |
09/11/1985 | EP0153939A1 Vaccine and antigen against paludism and preparation process thereof |
09/10/1985 | US4540564 Brain-specific drug delivery |
09/10/1985 | US4540486 Polyethylenimine bound chromatographic packing |
09/10/1985 | CA1193216A1 Process for preparing conjugated haptens and muramyl-peptides useful as immunogenic agents, and compositions containing the same |
09/10/1985 | CA1193210A1 Human hepatoma derived cell line, process for preparation thereof, and uses therefor |
09/10/1985 | CA1193207A1 Structural genes encoding the various allelic maturation forms of preprothaumatin, recombinant cloning vehicles, comprising said structural genes and expression thereof in transformed microbial host cells |